| 31° |
 |
Candriam Equities L Biotechnology - C Part (V)LU0317020203 |
|
6.40%
(31°)
|
54.04%
(39°)
|
14.45%
(38°)
|
10.65%
(16°)
|
Open overview
and rankings |
| 32° |
|
Candriam Equities L Biotechnology - C Part (I)LU0133360163 |
|
6.36%
(32°)
|
53.84%
(40°)
|
14.31%
(39°)
|
10.52%
(17°)
|
Open overview
and rankings |
| 33° |
|
Candriam Equities L Biotechnology - C Part (R - GBP - Unhedged)LU1269736911 |
|
6.35%
(33°)
|
55.23%
(37°)
|
15.11%
(37°)
|
11.29%
(15°)
|
Open overview
and rankings |
| 34° |
 |
Pictet-Biotech-HZ CHFLU2319668898 |
|
6.18%
(34°)
|
68.89%
(3°)
|
17.98%
(22°)
|
8.39%
(27°)
|
Open overview
and rankings |
| 35° |
|
Pictet-Biotech-I EURLU0255977372 |
|
6.13%
(35°)
|
66.54%
(10°)
|
17.35%
(24°)
|
8.21%
(29°)
|
Open overview
and rankings |
| 36° |
|
Candriam Equities L Biotechnology - C Part (I - GBP - Unhedged)LU1269737059 |
|
6.11%
(36°)
|
53.42%
(43°)
|
14.30%
(40°)
|
10.24%
(19°)
|
Open overview
and rankings |
| 37° |
|
Pictet Biotech I dy GBPLU0448836352 - Distribute dividends |
|
6.09%
(37°)
|
66.49%
(11°)
|
17.27%
(25°)
|
8.17%
(30°)
|
Open overview
and rankings |
| 38° |
|
Pictet-Biotech-P dy GBPLU0320646986 - Distribute dividends |
|
6.01%
(38°)
|
65.01%
(24°)
|
16.23%
(28°)
|
7.20%
(36°)
|
Open overview
and rankings |
| 39° |
|
Pictet-Biotech-R EURLU0255977539 |
|
5.99%
(39°)
|
63.90%
(30°)
|
15.48%
(32°)
|
6.49%
(37°)
|
Open overview
and rankings |
| 40° |
|
Pictet-Biotech-Z USDLU0258985083 |
|
5.98%
(40°)
|
68.11%
(4°)
|
18.42%
(17°)
|
9.29%
(22°)
|
Open overview
and rankings |
| 41° |
|
Pictet-Biotech-I USDLU0112497283 |
|
5.89%
(41°)
|
66.46%
(12°)
|
17.25%
(26°)
|
8.21%
(28°)
|
Open overview
and rankings |
| 42° |
|
Pictet-Biotech-P dy USDLU0208607159 |
|
5.81%
(42°)
|
64.98%
(25°)
|
16.21%
(29°)
|
7.25%
(35°)
|
Open overview
and rankings |
| 43° |
|
Pictet-Biotech-R USDLU0112497440 |
|
5.75%
(43°)
|
63.83%
(31°)
|
15.39%
(33°)
|
6.49%
(38°)
|
Open overview
and rankings |
| 44° |
 |
UBS (Lux) Equity Fund - Biotech (USD) P-accLU0069152568 |
|
4.70%
(44°)
|
53.22%
(44°)
|
8.27%
(45°)
|
4.62%
(43°)
|
Open overview
and rankings |
| 45° |
|
UBS (Lux) Equity Fund - Biotech (USD) Q-accLU0400035332 |
|
4.34%
(45°)
|
48.84%
(45°)
|
8.60%
(44°)
|
5.24%
(41°)
|
Open overview
and rankings |
| 46° |
 |
AXA FRAMLINGTON BIOTECH AXA Framlington Biotech Z AccGB00B784NS11 |
|
3.67%
(46°)
|
36.05%
(46°)
|
0.00%
(48°)
|
0.00%
(47°)
|
Open overview
and rankings |
| 47° |
|
AXA FRAMLINGTON BIOTECH AXA Framlington Biotech R AccGB0031007254 |
|
3.58%
(47°)
|
35.00%
(47°)
|
0.00%
(47°)
|
0.00%
(46°)
|
Open overview
and rankings |
| 48° |
|
Pictet-Biotech-P EURLU0255977455 |
|
0.00%
(48°)
|
0.00%
(48°)
|
0.00%
(46°)
|
0.00%
(49°)
|
Open overview
and rankings |
| 49° |
|
Pictet Biotech HP CHFLU0843168732 |
|
0.00%
(49°)
|
0.00%
(49°)
|
0.00%
(49°)
|
0.00%
(48°)
|
Open overview
and rankings |
SpA. Click on the individual Funds and read the overview with the expected return and risk indicators.
